DKSH signs distribution pact with Lactalis in Asia and Europe
Lactalis provides high-purity pharma lactose to formulate oral solid dose medicines, conforming with the lactose monohydrate monograph of the current Pharmacopoeia
DKSH has signed an exclusive distribution agreement with Lactalis, a leading manufacturer of lactose for the pharma industry, in Bangladesh, India, Indonesia, Thailand, Portugal, and Spain.
DKSH’s Business Unit Performance Materials will provide business development, marketing, sales, logistics, and distribution services for Lactalis’ pharma grade lactose for customers producing Finished Dosage Forms (FDFs), including tablets, pills, capsules, liquid solutions, among others in these key markets.
Lactalis provides high-purity pharma lactose to formulate oral solid dose medicines, conforming with the lactose monohydrate monograph of the current pharmacopoeia (Ph. Eur., USP-NF, and JP).
- Advertisement -